Osteocrin, a Novel Myokine, Prevents Diabetic Cardiomyopathy via Restoring Proteasomal Activity

Scientists investigated the role and underlying molecular basis of osteocrin (OSTN) in diabetic cardiomyopathy. Neonatal rat cardiomyocytes were isolated and stimulated with high glucose to verify the role of OSTN in vitro.